Market Cap (In EUR)
14.12 Million
Revenue (In EUR)
317.79 Thousand
Net Income (In EUR)
-4.22 Million
Avg. Volume
567.00
- Currency
- EUR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 3.32-24.0
- PE
- -
- EPS
- -
- Beta Value
- 0.364
- ISIN
- FR0010169920
- CUSIP
- F8580W104
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Stephane Ragusa
- Employee Count
- -
- Website
- https://www.predilife.com
- Ipo Date
- 2018-12-21
- Details
- Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France.
More Stocks
-
PFTAU
-
0755
-
FTSFortis Inc.
FTS
-
BLX
-
SANBLUESanblue Corporation Limited
SANBLUE
-
300720
-
MANUGRAPHManugraph India Limited
MANUGRAPH
-
AGBAWAGBA Acquisition Limited
AGBAW